Tag: Johnson & Johnson

Categories USA

Johnson & Johnson’s newly-approved Covid vaccine met with pushback as Catholic diocese condemns it for ‘ties to abortion cells’

Posted on Posted onBy Editor

As Johnson & Johnson rolls out its freshly approved Covid-19 vaccine in the US, it faces a religious controversy as the Catholic Archdiocese of New Orleans has labeled it “morally compromised” over links to abortion cells. … Read More >Johnson & Johnson’s newly-approved Covid vaccine met with pushback as Catholic diocese condemns it for ‘ties to abortion cells’

Categories World

‘Quick, easy and not so painful’: S. Africa’s Ramaphosa gets J&J Covid jab as nation turns back on AstraZeneca

Posted on Posted onBy Editor

South Africa’s president has been vaccinated with Johnson & Johnson’s Covid-19 jab, joining thousands of healthcare workers taking part in a trial to test the efficacy of the single-dose vaccine against the local virus variant. … Read More >‘Quick, easy and not so painful’: S. Africa’s Ramaphosa gets J&J Covid jab as nation turns back on AstraZeneca

Categories World

S. Africa to administer globally unapproved J&J Covid-19 shot in healthcare workers trial, looks to offload AstraZeneca jab

Posted on Posted onBy Editor

South Africa is set to kick off a trial of Johnson & Johnson’s Covid-19 jab, administering the vaccine to healthcare workers after a small study showed AstraZeneca’s jab to be ineffective against the country’s dominant variant. … Read More >S. Africa to administer globally unapproved J&J Covid-19 shot in healthcare workers trial, looks to offload AstraZeneca jab

Categories World

South Africa to give up to 500,000 health workers Johnson & Johnson Covid jab amid AstraZeneca efficacy concerns

Posted on Posted onBy Editor

Between 350,000 and 500,000 health workers in South Africa are to be given the Johnson & Johnson Covid-19 vaccine, a top government medical adviser said, amid concerns over the AstraZeneca jab’s efficacy against the local strain. … Read More >South Africa to give up to 500,000 health workers Johnson & Johnson Covid jab amid AstraZeneca efficacy concerns

Categories EU

Switzerland delays approval of AstraZeneca and Johnson & Johnson Covid-19 vaccines due to ‘insufficient data’

Posted on Posted onBy Editor

The Swiss drugs regulator will delay its approval of the two Covid-19 vaccines developed by AstraZeneca and Johnson & Johnson until it receives more data on their efficacy at preventing the virus, the agency said on Wednesday. … Read More >Switzerland delays approval of AstraZeneca and Johnson & Johnson Covid-19 vaccines due to ‘insufficient data’

Categories World

Johnson & Johnson one-dose Covid-19 vaccine shown to be 66 percent effective against virus in phase 3 trials

Posted on Posted onBy Editor

The Covid-19 vaccine being developed by US company Johnson & Johnson has been found to be 66 percent effective at treating moderate and severe infections 28 days after vaccination, a large-scale phase 3 clinical trial has found. … Read More >Johnson & Johnson one-dose Covid-19 vaccine shown to be 66 percent effective against virus in phase 3 trials

Categories Shows

Last-ditch lawsuits: Is Trump grasping at straws?

Posted on Posted onBy Editor

The electoral scoreboard has awarded the presidency to Joe Biden, but pundits are still rattled by the glaring omission of a ‘blue wave’. Plus, a growing number of Democrats may be considering moving on from Pelosi’s leadership in the House. Also, Glenn Greenwald cuts ties with the Intercept, alleging censorship by the very platform he founded. … Read More >Last-ditch lawsuits: Is Trump grasping at straws?

Categories USA

Johnson & Johnson, AstraZeneca to Resume Coronavirus Vaccine Clinical Trials in US

Posted on Posted onBy Editor

American pharmaceutical company Johnson & Johnson announced halting its COVID-19 vaccine clinical trials on 12 October after one of its program participants exhibited an “unexplained illness”. The British company paused worldwide trials on 6 September after it was revealed that neurological illnesses were being reported among participants. … Read More >Johnson & Johnson, AstraZeneca to Resume Coronavirus Vaccine Clinical Trials in US